## **Core Concept**
The patient presents with symptoms and ECG findings suggestive of **atrial fibrillation (AF) with rapid ventricular response**, characterized by an irregularly irregular rhythm and broad complex tachycardia. Atrial fibrillation is a type of supraventricular tachycardia (SVT) that requires prompt management to prevent complications.

## **Why the Correct Answer is Right**
The best initial pharmacotherapy for a hemodynamically stable patient with atrial fibrillation and rapid ventricular response, when DC cardioversion is not available, involves rate or rhythm control. **Rate control** aims to control the ventricular rate, while **rhythm control** aims to convert AF to sinus rhythm. For rate control, **beta-blockers** (e.g., metoprolol) and **non-dihydropyridine calcium channel blockers** (e.g., verapamil, diltiazem) are commonly used. Among the options provided, **metoprolol (a beta-blocker)** is an appropriate initial choice for rate control in a hemodynamically stable patient.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is not provided, but typically, incorrect options might include medications not suitable for rate or rhythm control in AF, such as digoxin for immediate rate control in acute settings or medications not indicated for this specific scenario.
- **Option B:** If this option represents a rhythm control agent like amiodarone, while it could be considered, it's not typically the first line for rate control. Amiodarone can be used for rhythm control but has a broader side effect profile.
- **Option C:** If this option is a dihydropyridine calcium channel blocker (e.g., nifedipine), it's less suitable because dihydropyridines are more likely to cause reflex tachycardia and are not the first choice for rate control in AF.
- **Option D:** If this option represents an anticoagulant or an agent not directly used for rate or rhythm control in AF, it would be incorrect as the initial management for controlling symptoms and heart rate.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that in a hemodynamically stable patient with atrial fibrillation and rapid ventricular response, **beta-blockers and non-dihydropyridine calcium channel blockers are first-line for rate control**. Always assess the patient's hemodynamic status before choosing an agent.

## **Correct Answer:** . **Metoprolol**